Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy | |
Fan, Lingling; Chen, Jun; Zhang, Xiaoyan; Liu, Yingtao; Xu, Congjian | |
刊名 | GYNECOLOGIC ONCOLOGY
![]() |
2014 | |
卷号 | 135期号:1 |
关键词 | Follicle-stimulating hormone polypeptide (FSHP) Follicle stimulating hormone receptor (FSHR) Ovarian carcinoma Paclitaxel (PTX) Lymphatic metastasis |
ISSN号 | 0090-8258 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4881902 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Fan, Lingling,Chen, Jun,Zhang, Xiaoyan,et al. Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy[J]. GYNECOLOGIC ONCOLOGY,2014,135(1). |
APA | Fan, Lingling,Chen, Jun,Zhang, Xiaoyan,Liu, Yingtao,&Xu, Congjian.(2014).Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy.GYNECOLOGIC ONCOLOGY,135(1). |
MLA | Fan, Lingling,et al."Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy".GYNECOLOGIC ONCOLOGY 135.1(2014). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论